Medpage Today on MSN1d
GLP-1 Drugs Could Help People With Alcohol Use Disorder
Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...
Medpage Today on MSN6d
FDA Adds New Warning to GLP-1 Drugs
The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide ( Ozempic, Wegovy, Rybelsus ), ...
Ozempic May Help You Cut Back On Alcohol. Here's Why.
In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...
TCTMD1d
Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key
In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists, the medical community ...
The American Journal of Managed Care1d
GLP-1s Could Help Reduce Alcohol Addiction, Study Finds
Semaglutide and liraglutide are associated with reduced AUD and SUD-related hospitalization risks, unlike other GLP-1 ...
Teens Are Being Prescribed Wegovy and GLP-1s at Record Rates. Should Parents Be Worried?
It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...
News Medical on MSN3d
GLP-1, SGLT2 Drugs Cut Heart Risk for Stroke Survivors
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...
New Atlas4d
Weight-loss pill passes important safety test in clinical trial
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Yahoo Finance3d
GLP-1, SGLT2 medications may lower stroke survivor s risk of future heart attack, stroke
The first GLP-1 medication was prescribed beginning in 2006, and the authors included cases beginning in 2000 to increase the power of the study, they noted. (NewMediaWire) - November 11, 2024 - ...
Onlymyhealth6d
FDA Issues New Warning For Popular Weight Loss Drugs—Here's What You Need To Know
The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to ...
News Medical on MSN20h
GLP-1 agonists linked to fewer hospitalizations in alcohol use disorder patients
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...